Characteristics of autologous protein solution and leucocyte-poor platelet-rich plasma for the treatment of osteoarthritis of the knee

被引:14
作者
Wasai, Shiho [1 ,2 ]
Sato, Masato [1 ,2 ]
Maehara, Miki [1 ,2 ]
Toyoda, Eriko [1 ,2 ]
Uchiyama, Ryoka [1 ,2 ]
Takahashi, Takumi [1 ,2 ]
Okada, Eri [1 ,2 ]
Iwasaki, Yoshiko [1 ,2 ]
Suzuki, Satoko [1 ,2 ]
Watanabe, Masahiko [1 ,2 ]
机构
[1] Tokai Univ, Dept Orthopaed Surg, Surg Sci, Sch Med, Isehara, Kanagawa, Japan
[2] Tokai Univ, Ctr Musculoskeletal Innovat Res & Adv C MiRA, Grad Sch Med, Isehara, Kanagawa, Japan
关键词
NECROSIS-FACTOR-ALPHA; MATRIX METALLOPROTEINASES; SOLUBLE FAS; SERUM; MANAGEMENT;
D O I
10.1038/s41598-020-67099-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recently, platelet-rich plasma (PRP) has received attention as a treatment for patients with osteoarthritis of the knee (OAK), a chronic degenerative disease, to bridge the gap between conservative and surgical treatments. Here, we investigated the differences in the humoral factors present in two types of PRP purified using the Autologous Protein Solution (APS) kit (group Z; leucocyte-rich PRP) or the Cellaid Serum Collection Set P type (group J; leucocyte-poor [LP]-PRP). Differences in humoral factors between healthy subjects (n=10) and OAK patients (n=12; group Z=6, group J=6), and the relationship between humoral factors and clinical outcome scores were investigated. Both anti-inflammatory and inflammatory cytokines were highly enriched in APS. The concentrations of tumour necrosis factor (TNF)-alpha, platelet-derived growth factor, fibroblast growth factor, soluble TNF-receptor 2, soluble Fas and transforming growth factor-beta 1 were higher in group Z, while the total amounts were higher in group J. The concentration of interleukin-1 receptor antagonist was positively correlated with the magnitude of change in the clinical outcome score and may contribute to improving knee-joint function. This is the first description of the humoral factors in APS and LP-PRP prepared from healthy subjects or OAK patients of Asian descent.
引用
收藏
页数:11
相关论文
共 26 条
[1]   A high plasma concentration of TNF-α is associated with dementia in centenarians [J].
Bruunsgaard, H ;
Andersen-Ranberg, K ;
Jeune, B ;
Pedersen, AN ;
Skinhoj, P ;
Pedersen, BK .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 1999, 54 (07) :M357-M364
[2]   PROTECTION FROM FAS-MEDIATED APOPTOSIS BY A SOLUBLE FORM OF THE FAS MOLECULE [J].
CHENG, JH ;
ZHOU, T ;
LIU, CD ;
SHAPIRO, JP ;
BRAUER, MJ ;
KIEFER, MC ;
BARR, PJ ;
MOUNTZ, JD .
SCIENCE, 1994, 263 (5154) :1759-1762
[3]   TGF-β and osteoarthritis [J].
Davidson, E. N. Blaney ;
van der Kraan, P. M. ;
van den Berg, W. B. .
OSTEOARTHRITIS AND CARTILAGE, 2007, 15 (06) :597-604
[4]  
Dhillon MS, 2017, SICOT-J, V3, DOI 10.1051/sicotj/2017004
[5]   Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis [J].
Filardo, Giuseppe ;
Kon, Elizaveta ;
Buda, Roberto ;
Timoncini, Antonio ;
Di Martino, Alessandro ;
Cenacchi, Annarita ;
Fornasari, Pier Maria ;
Giannini, Sandro ;
Marcacci, Maurilio .
KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2011, 19 (04) :528-535
[6]   Osteoarthritis and cartilage: the role of cytokines. [J].
Goldring M.B. .
Current Rheumatology Reports, 2000, 2 (6) :459-465
[7]   Accumulation of soluble Fas in inflamed joints of patients with rheumatoid arthritis [J].
Hasunuma, T ;
Kayagaki, N ;
Asahara, H ;
Motokawa, S ;
Kobata, T ;
Yagita, H ;
Aono, H ;
Sumida, T ;
Okumura, K ;
Nishioka, K .
ARTHRITIS AND RHEUMATISM, 1997, 40 (01) :80-86
[8]   Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis [J].
Jang S.-J. ;
Kim J.-D. ;
Cha S.-S. .
European Journal of Orthopaedic Surgery & Traumatology, 2013, 23 (5) :573-580
[9]   Interleukin-1β signaling in osteoarthritis - chondrocytes in focus [J].
Jenei-Lanzl, Zsuzsa ;
Meurer, Andrea ;
Zaucke, Frank .
CELLULAR SIGNALLING, 2019, 53 :212-223
[10]   Clinical Outcomes of Knee Osteoarthritis Treated With an Autologous Protein Solution Injection A 1-Year Pilot Double-Blinded Randomized Controlled Trial [J].
Kon, Elizaveta ;
Engebretsen, Lars ;
Verdonk, Peter ;
Nehrer, Stefan ;
Filardo, Giuseppe .
AMERICAN JOURNAL OF SPORTS MEDICINE, 2018, 46 (01) :171-180